Hepion Pharmaceuticals, Inc. (HEPA) Total liabilities 2020–2023
Hepion Pharmaceuticals, Inc. (HEPA) total liabilities at each fiscal year-end, per SEC filings.
$10.8MFY2023 · since FY2020: $8.1M → $10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $10.8M | +4.1% |
| FY2022 | $10.4M | -1.6% |
| FY2021 | $10.6M | +29.9% |
| FY2020 | $8.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HEPA financial trends
HEPA RevenueHEPA Net incomeHEPA Net marginHEPA Gross profitHEPA Gross marginHEPA Operating incomeHEPA Operating marginHEPA Operating cash flowHEPA Free cash flowHEPA Capital expendituresHEPA Return on equityHEPA Stock buybacksHEPA Dividends paidHEPA Total assetsHEPA Shareholders’ equityHEPA overview →